Sunesis brings in $15.4M to fund leukemia study

Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS) raised $15.4 million through the sale of 44.1 million units at $0.35 per unit in a follow-on underwritten by Cowen and ThinkEquity. Each unit consists of a share and a five-year warrant to purchase 0.5 of a share, with each whole warrant exercisable at $0.42 per share. ...